Xelpmoc Design and Tech Ltd

Board approvals

• Unaudited standalone and consolidated results for quarter ended June 30, 2026 approved; Limited Review Reports attached.

Key appointment

• Arvind Khandelwal appointed Chief Business Officer effective Aug 21, 2026.

ESOP 2026

• ESOP 2026 approved; up to 7,41,116 options; exercise price at least face value.
• Vesting after one year; approvals from shareholders and exchanges pending.

Auditor notes on going concern

• Soultrax Studios Pvt Ltd: accumulated losses and eroded net worth; going concern risk.
• Signal Analytics Pvt Ltd: going concern risk flagged; management evaluating support needs.

Consolidation & impairment

• Restricted consolidation of Soultrax due to impairment; no further losses recognized.
• Restricted recognition of associate Xperience India Pvt Ltd; no further losses recognized.

Capital changes

• 40,000 shares allotted on option conversion; paid-up capital Rs 14,79,94,930.
• 135,681 options granted to employees.

Dividend & shareholding

• Board did not recommend any dividend.

Operational & segment info

• Single segment: software development services; no NBFC operations.

Investor complaints

• Investor complaints: Nil for the quarter.

Financial results

• Unaudited standalone and consolidated Q1 2026 results approved; quarter ended June 30, 2026.
• Limited review reports on results attached.

Key appointment

• Arvind Khandelwal appointed Chief Business Officer, effective August 21, 2026.

ESOP scheme

• Xelpmoc ESOP 2026 approved; up to 7,41,116 options, subject to shareholder and exchange approvals.

Share capital and options

• 40,000 shares issued on option conversion; paid-up capital increased to Rs 14,79,94,930.
• 135,681 options granted to employees in Q1 2026.

Consolidation and going concern

• Restricted consolidation of Soultrax Studios Pvt Ltd; impairment; no further losses recognized.
• Restricted recognition of Xperience India Private Limited as associate; impairment already recognized.

Dividend

• Board did not recommend any dividend for the quarter.

Meeting Details

• Board meeting scheduled on Aug 14, 2026; time and venue not disclosed.

Key Agenda Items

• Consider and approve unaudited standalone and consolidated financial results for the quarter ended June 30, 2026.

Dematerialisation/rematerialisation actions

• Dematerialisation actions were completed within 15 days of receipt of securities certificates from the DP.
• The dematerialised securities are listed on the stock exchanges where the earlier issued securities are listed.
• The certificate of security forwarded by the DP was mutilated and cancelled.
• The depository name was substituted as the registered owner in the records.

Meeting Details

• Board meeting scheduled for Friday, May 29, 2026.

Key Agenda Items

• Consider and approve audited standalone financial results for year ended March 31, 2026.
• Consider and approve audited consolidated financial results for year ended March 31, 2026.

Other Notes

• No additional material items were disclosed in this chunk.